Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone Marrow Cells in Suppressing Leukemic Cell Growth.

Viktor I. Seledtsov1, Vladimir V. Sennikov, Galina V. Seledtsova

  • 1Institute of Clinical Immunology, Siberian Branch of Russian Academy of Medical Sciences, Novosibirsk, Russia.

Russian Journal of Immunology : RJI : Official Journal of Russian Society of Immunology
|April 11, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IL-2-Activated Killer Cells and Native Cytokines in Treatment of Patients with Advanced Cancer.

Russian journal of immunology : RJI : official journal of Russian Society of Immunology·2003
Same author

Production of Peptide of Retroviral Origin in Sera of Patients with Chronic Myeloid Leukemia at Acute Phase.

Russian journal of immunology : RJI : official journal of Russian Society of Immunology·2003
Same author

The Effect of Inactivated Ebola Virus on Immune and Hemopoietic Cell Activity.

Russian journal of immunology : RJI : official journal of Russian Society of Immunology·2003
Same author

A Role of Endogenous Retroviral MCF env Gene in Proliferation of Pluripotent Hemopoietic Progenitors in Mice.

Russian journal of immunology : RJI : official journal of Russian Society of Immunology·2003
Same author

The Peculiarities of the Immune Status in Mice with Different Level of Behavioral Reactions.

Russian journal of immunology : RJI : official journal of Russian Society of Immunology·2003
Same author

Research Activity at the Institute of Clinical Immunology in Accordance with Actual Problems in Immunology.

Russian journal of immunology : RJI : official journal of Russian Society of Immunology·2003

Normal bone marrow cells (BMC) can suppress leukemia cell growth without causing cell death. This anti-leukemia activity is antigen-non-specific and may be enhanced by lymphokines like IL-2 and IFN-gamma.

Area of Science:

  • Hematology
  • Immunology
  • Cancer Biology

Background:

  • Leukemia poses a significant challenge in cancer therapy.
  • Understanding the mechanisms of leukemia cell growth control is crucial.
  • Bone marrow cells (BMC) are investigated for their potential anti-leukemia properties.

Purpose of the Study:

  • To review experimental findings on the capacity of bone marrow cells (BMC) to control leukemic cell growth.
  • To elucidate the nature and characteristics of BMC with cytostatic effects on leukemia cells.

Main Methods:

  • In vitro experiments assessing the proliferative activity of leukemic cells upon co-culture with BMC.
  • Characterization of cytostatic BMC, including density and cell type analysis.
  • Long-term cultivation of bone marrow to identify cells associated with cytostatic activity.

Related Experiment Videos

  • Investigation of soluble factors and cell-to-cell interactions in BMC-mediated cytostasis.

    • Main Results:

    • Normal BMC exhibit dose-dependent suppression of leukemic cell proliferation in vitro.
    • The cytostatic effect of BMC is antigen-non-specific and does not induce cell death.
    • Cytostatic BMC are distinct from mature immune cells and possess lower buoyant density.
    • These cells are found in both aggregated and non-aggregated BMC fractions.
    • Radioresistant stromal cells in long-term bone marrow cultures are associated with cytostatic activity.
    • Both soluble factors and direct cell-to-cell contact contribute to BMC-mediated cytostasis.

    Conclusions:

    • Bone marrow cells possess inherent cytostatic properties against leukemia.
    • The cytostatic mechanism involves non-specific suppression of proliferation without cell death.
    • Stromal cells and soluble factors, potentially influenced by lymphokines (IL-2, IFN-gamma), play a role in this process.
    • Further research into enhancing BMC cytostatic activity could offer novel therapeutic strategies for leukemia.